Valproic acid intensifies epileptiform activity in the hippocampal pyramidal neurons

Neuroscience Research

Volumn 35, Issue 4, 1999, Pages 299-307

  Otoom, Sameer A ^a   Alkadhi, Karim A ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

Bicuculline; Hippocampus; Magnesium free artificial cerebrospinal fluid (ACSF); Proepileptic; Valproic acid; Veratridine

Indexed keywords

BICUCULLINE; SODIUM CHANNEL; VALPROIC ACID; VERATRIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EPILEPSY; HIPPOCAMPUS; MALE; MEMBRANE STEADY POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SEIZURE;

ACTION POTENTIALS; ANIMALS; BICUCULLINE; DISEASE MODELS, ANIMAL; EPILEPSY; GABA ANTAGONISTS; HIPPOCAMPUS; MALE; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHANNELS; VALPROIC ACID;

EID: 0032697866     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-0102(99)00099-1     Document Type: Article

References (32)

1. Alkadhi K.A., Banks F.W. Pre- and postsynaptic actions of valproic acid at the frog neuromuscular junction. Brain Res. 306:1984;388-390.
2. Alkadhi K.A., Tian L.M. Veratridine-enhanced persistent sodium current induces bursting in CA1 pyramidal neurons. Neuroscience. 71:1996;625-632.
3. Altrup U., Reith H., Speckmann E.J. Effects of valproate in a model nervous system (buccal ganglia of Helix pomatia): II. Epileptogenic actions. Epilepsia. 33:1992;753-759.
4. Berkovic S.F. Aggravation of generalized epilepsies. Epilepsia. 39:1998;S11-S14.
5. Buchhalter J.R., Dichter M.A. Effects of valproic acid in cultured mammalian neurons. Neurology. 36:1986;259-262.
6. Capocchi G., Balducci A., Cecconi M., Pelli M.A., Picchiarelli A., Silvestrelli G., Zampolini M. Valproate-induced epileptic tonic status. Seizure. 7:1998;237-241. (in process citation).
7. Chadwick D.W., Cumming W.J., Livingstone I., Cartlidge N.E. Acute intoxication with sodium valproate. Ann. Neurol. 6:1979;552-553.
8. Chapman A., Keane P.E., Meldrum B.S., Simiand J., Vernieres J.C. Mechanism of anticonvulsant action of valproate. Prog. Neurobiol. 19:1982;315-359.
9. Cotariu D., Zaidman J.L., Evans S. Neurophysiological and biochemical changes evoked by valproic acid in the central nervous system. Prog. Neurobiol. 34:1990;343-354.
10. Cutler M.G., Horton R.W. Paradoxical enhancement of seizures in the gerbil after chronic treatment with sodium valproate. Neuropharmacology. 27:1988;617-621.
11. Elliott E.M., Malouf A.T., Catterall W.A. Role of calcium channel subtypes in calcium transients in hippocampal CA3 neurons. J. Neurosci. 15:1995;6433-6444.
12. Fromm G.H., Glass J.D., Chattha A.S., Martinez A.J. Effect of anticonvulsant drugs on inhibitory and excitatory pathways. Epilepsia. 22:1981;65-73.
13. Guerrini R., Belmonte A., Genton P. Antiepileptic drug-induced worsening of seizures in children. Epilepsia. 39:1998;S2-S10.
14. Hansen A.J., Lauritzen M. The role of spreading depression in acute brain disorders. Ann. Acad. Bras. Cien. 54:1984;457-479.
15. Hille, B., 1992. Modifiers of gating. In: Ionic Channels of Excitable Membranes. Sinauer Associates, Sunderland, MA.
16. Janssen F., Rambeck B., Schnabel R. Acute valproate intoxication with fatal outcome in an infant. Neuropediatrics. 16:1985;235-238.
17. Kelly K.M., Gross R.A., Macdonald R.L. Valproic acid selectively reduces the low-threshold (T) calcium current in rat nodose neurons. Neurosci. Lett. 116:1990;233-238.
18. Li Y., Dai X., Yang S. Effects of sodium valproate on bicuculline-induced epileptiform activity in rat hippocampal slices in vitro. Hua Hsi I Ko Ta Hsueh Hsueh Pao. 22:1991;31-40.
19. Lombardo A.J., Kuzniecky R., Powers R.E., Brown G.B. Altered relative expression of two human brain sodium channel mRNAs in patients with epilepsy. Brain Res. Mol. Brain Res. 35:1996;84-90.
20. 2+ of NMDA responses in spinal cord neurones. Nature. 309:1984;261-263.
21. Nosek T.M. How valproate and phenytoin affect the ionic conductances and active transport characteristics of the crayfish giant axon. Epilepsia. 22:1981;651-665.
22. Olsen R.W. The GABA postsynaptic membrane receptor-ionophore complex. Site of action of convulsant and anticonvulsant drugs. Mol. Cell. Biochem. 39:1981;261-279.
23. Otoom S., Tian L.M., Alkadhi K.A. Veratridine-treated brain slices: a cellular model for epileptiform activity. Brain Res. 789:1998;150-156.
24. Perreault P., Tancredi V., Avoli M. Failure of the antiepileptic drug valproic acid to modify synaptic and non-synaptic responses of CA1 hippocampal pyramidal cells maintained 'in vitro'. Epilepsy Res. 3:1989;227-231.
25. Piredda S., Yonekawa W., Whittingham T.S., Kupferberg H.J. Effects of antiepileptic drugs on pentylenetetrazole-induced epileptiform activity in the in vitro hippocampus. Epilepsia. 27:1986;341-346.
26. Rose D. Facilitation of bicuculline- and picrotoxin-induced seizures by sodium valproate in rats. Arch. Int. Pharmacodyn. Ther. 239:1979;78-85.
27. Sannita W.G. Valproate acute administration, EEG epileptic abnormalities, and ammonemia. Neurology. 42:1992;2003-2005.
28. Shelton R.C., Grebb J.A., Freed W.J. Induction of seizures in mice by intracerebroventricular administration of the calcium channel agonist BAY k 8644. Brain Res. 402:1987;399-402.
29. Slater G.E., Johnston D. Sodium valproate increases potassium conductance in Aplysia neurons. Epilepsia. 19:1978;379-384.
30. Tian L.M., Alkadhi K.A. Valproic acid inhibits the depolarizing rectification in neurons of rat amygdala. Neuropharmacology. 33:1994;1131-1138.
31. Urban L., Aitken P.G., Crain B.J., Friedman A.H., Somjen G.G. Correlation between function and structure in 'epileptic' human hippocampal tissue maintained in vitro. Epilepsia. 34:1993;54-60.
32. Whittle S.R., Turner A.J. Effects of the anticonvulsant sodium valproate on gamma-aminobutyrate and aldehyde metabolism in ox brain. J. Neurochem. 31:1978;1453-1459.